BVXVW - Biondvax Pharmaceuticals Ltd Warrants 2015-15.5.20 On Shs
Previous close
7.52
0 0%
Share volume: 0
Last Updated: Wed 13 May 2020 06:00:00 AM CEST
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.52
0.00
0.00%
Summary score
59%
Profitability
75%
Dept financing
25%
Liquidity
25%
Performance
60%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BVXVW | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | 0% | -17.97% | -3.34% | -14.58% |
| Return on assets | 0% | -15.67% | -1.22% | -13.27% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 0% | 161.19% | -511.62% | 733.8% |
| Profitability | 75% | 5% | 0% | 25% |
| Total debt ratio | 0% | 14.54% | 27.48% | 9.46% |
| Debt ratio change over time | 0% | -0.91% | -1.02% | -1% |
| Dept financing | 25% | 13% | 25% | 9% |
| Current Ratio | 0% | 11.14% | 16.04% | 20.26% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 0% | 5.36% | 4.16% | 19.67% |
| Liquididy | 25% | 17% | 24% | 50% |
| Short-term ratios | BVXVW | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | 0% | -8.91% | -6.16% | -11.27% |
| Return on assets | 0% | -8.75% | -5.93% | -10.9% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | 0% | 121.89% | -177.6% | 631.03% |
| Profitability | 75% | 5% | 0% | 25% |
| Total debt ratio | 0% | 10.61% | 9.15% | 6.33% |
| Debt ratio change over time | 0% | -0.91% | -1.02% | -0.99% |
| Dept financing | 25% | 25% | 22% | 15% |
| Current Ratio | 0% | 11.14% | 16.04% | 20.26% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 0% | 5.36% | 4.16% | 19.67% |
| Liquididy | 25% | 21% | 25% | 50% |